Securities,
Civil Litigation
Feb. 5, 2019
Defense limits damages in major securities fraud verdict
A federal jury returned a verdict Monday that was a fraction of what plaintiffs sought in a billion-dollar case on Monday against a pharmaceutical company, authorizing about 5 percent of the damages requested in the largest securities fraud trial in 10 years.
SANTA ANA -- A federal jury returned a verdict Monday that was a fraction of what plaintiffs sought in a billion-dollar case against a pharmaceutical company, authorizing about 5 percent of the damages requested in the largest securities fraud trial in 10 years.
Following a two-week trial ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
